-
Je něco špatně v tomto záznamu ?
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
IE. Lundberg, A. Tjärnlund, M. Bottai, VP. Werth, C. Pilkington, M. Visser, L. Alfredsson, AA. Amato, RJ. Barohn, MH. Liang, JA. Singh, R. Aggarwal, S. Arnardottir, H. Chinoy, RG. Cooper, K. Dankó, MM. Dimachkie, BM. Feldman, IG. Torre, P....
Jazyk angličtina Země Velká Británie
Typ dokumentu konsensus - konference, časopisecké články, směrnice pro lékařskou praxi, validační studie
NLK
ProQuest Central
od 1939-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 1939-01-01 do Před 6 měsíci
Family Health Database (ProQuest)
od 1939-01-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- biopsie normy MeSH
- diferenciální diagnóza MeSH
- dítě MeSH
- dospělí MeSH
- konsensus MeSH
- kosterní svaly patologie MeSH
- lidé MeSH
- myozitida klasifikace diagnóza MeSH
- pravděpodobnost MeSH
- referenční hodnoty MeSH
- revmatologie organizace a řízení normy MeSH
- senzitivita a specificita MeSH
- společnosti lékařské organizace a řízení MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- směrnice pro lékařskou praxi MeSH
- validační studie MeSH
- Geografické názvy
- Evropa MeSH
- Spojené státy americké MeSH
OBJECTIVE: To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups. METHODS: Candidate variables were assembled from published criteria and expert opinion using consensus methodology. Data were collected from 47 rheumatology, dermatology, neurology and paediatric clinics worldwide. Several statistical methods were used to derive the classification criteria. RESULTS: Based on data from 976 IIM patients (74% adults; 26% children) and 624 non-IIM patients with mimicking conditions (82% adults; 18% children), new criteria were derived. Each item is assigned a weighted score. The total score corresponds to a probability of having IIM. Subclassification is performed using a classification tree. A probability cut-off of 55%, corresponding to a score of 5.5 (6.7 with muscle biopsy) 'probable IIM', had best sensitivity/specificity (87%/82% without biopsies, 93%/88% with biopsies) and is recommended as a minimum to classify a patient as having IIM. A probability of ≥90%, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy), corresponds to 'definite IIM'. A probability of <50%, corresponding to a score of <5.3 (<6.5 with muscle biopsy), rules out IIM, leaving a probability of ≥50 to <55% as 'possible IIM'. CONCLUSIONS: The European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology and paediatric groups. They employ easily accessible and operationally defined elements, and have been partially validated. They allow classification of 'definite', 'probable' and 'possible' IIM, in addition to the major subgroups of IIM, including juvenile IIM. They generally perform better than existing criteria.
Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
Department of Neurology Academic Medical Centre Amsterdam The Netherlands
Department of Neurology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA
Department of Neurology University of Kansas Medical Center Kansas City Kansas USA
Department of Pediatrics Duke University Durham North Carolina USA
Department of Public Health Oregon State University Corvallis Oregon USA
Department of Rheumatology and Immunology People's Hospital of Beijing University Beijing China
Department of Rheumatology Great Ormond Street Hospital for Children NHS Trust London UK
Department of Rheumatology King's College Hospital NHS Foundation Trust London UK
Division of Rheumatology Mayo Clinic College of Medicine Rochester New York USA
Institute for Environmental Medicine Karolinska Institutet Stockholm Sweden
Paediatric Clinic of Rheumatology Institute of Rheumatology Warsaw Poland
Section of Rheumatology Oslo University Hospital Rikshospitalet Oslo Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016252
- 003
- CZ-PrNML
- 005
- 20180515103959.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/annrheumdis-2017-211468 $2 doi
- 035 __
- $a (PubMed)29079590
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Lundberg, Ingrid E $u Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
- 245 10
- $a 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups / $c IE. Lundberg, A. Tjärnlund, M. Bottai, VP. Werth, C. Pilkington, M. Visser, L. Alfredsson, AA. Amato, RJ. Barohn, MH. Liang, JA. Singh, R. Aggarwal, S. Arnardottir, H. Chinoy, RG. Cooper, K. Dankó, MM. Dimachkie, BM. Feldman, IG. Torre, P. Gordon, T. Hayashi, JD. Katz, H. Kohsaka, PA. Lachenbruch, BA. Lang, Y. Li, CV. Oddis, M. Olesinska, AM. Reed, L. Rutkowska-Sak, H. Sanner, A. Selva-O'Callaghan, YW. Song, J. Vencovsky, SR. Ytterberg, FW. Miller, LG. Rider, . ,
- 520 9_
- $a OBJECTIVE: To develop and validate new classification criteria for adult and juvenile idiopathic inflammatory myopathies (IIM) and their major subgroups. METHODS: Candidate variables were assembled from published criteria and expert opinion using consensus methodology. Data were collected from 47 rheumatology, dermatology, neurology and paediatric clinics worldwide. Several statistical methods were used to derive the classification criteria. RESULTS: Based on data from 976 IIM patients (74% adults; 26% children) and 624 non-IIM patients with mimicking conditions (82% adults; 18% children), new criteria were derived. Each item is assigned a weighted score. The total score corresponds to a probability of having IIM. Subclassification is performed using a classification tree. A probability cut-off of 55%, corresponding to a score of 5.5 (6.7 with muscle biopsy) 'probable IIM', had best sensitivity/specificity (87%/82% without biopsies, 93%/88% with biopsies) and is recommended as a minimum to classify a patient as having IIM. A probability of ≥90%, corresponding to a score of ≥7.5 (≥8.7 with muscle biopsy), corresponds to 'definite IIM'. A probability of <50%, corresponding to a score of <5.3 (<6.5 with muscle biopsy), rules out IIM, leaving a probability of ≥50 to <55% as 'possible IIM'. CONCLUSIONS: The European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for IIM have been endorsed by international rheumatology, dermatology, neurology and paediatric groups. They employ easily accessible and operationally defined elements, and have been partially validated. They allow classification of 'definite', 'probable' and 'possible' IIM, in addition to the major subgroups of IIM, including juvenile IIM. They generally perform better than existing criteria.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a biopsie $x normy $7 D001706
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a Evropa $7 D005060
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kosterní svaly $x patologie $7 D018482
- 650 _2
- $a myozitida $x klasifikace $x diagnóza $7 D009220
- 650 _2
- $a pravděpodobnost $7 D011336
- 650 _2
- $a referenční hodnoty $7 D012016
- 650 _2
- $a revmatologie $x organizace a řízení $x normy $7 D012219
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a společnosti lékařské $x organizace a řízení $7 D012955
- 650 _2
- $a Spojené státy americké $7 D014481
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Tjärnlund, Anna $u Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Bottai, Matteo $u Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Werth, Victoria P $u Department of Dermatology, Philadelphia VAMC and Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- 700 1_
- $a Pilkington, Clarissa $u Department of Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- 700 1_
- $a Visser, Marianne de $u Department of Neurology, Academic Medical Centre, Amsterdam, The Netherlands.
- 700 1_
- $a Alfredsson, Lars $u Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Amato, Anthony A $u Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- 700 1_
- $a Barohn, Richard J $u Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- 700 1_
- $a Liang, Matthew H $u Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, and Section of Rheumatology, Boston VA Healthcare, Boston, Massachusetts, USA.
- 700 1_
- $a Singh, Jasvinder A $u Mayo Clinic College of Medicine, Rochester, Minnesota, USA. University of Alabama and Birmingham VA Medical Center, Birmingham, USA.
- 700 1_
- $a Aggarwal, Rohit $u Division of Rheumatology and Clinical Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- 700 1_
- $a Arnardottir, Snjolaug $u Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Chinoy, Hector $u National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, UK.
- 700 1_
- $a Cooper, Robert G $u MRC/ARUK Institute of Ageing and Chronic Disease, Faculty of Health & Life Sciences, University of Liverpool, Liverpool, UK.
- 700 1_
- $a Dankó, Katalin $u Division of Immunology, 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Dimachkie, Mazen M $u Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- 700 1_
- $a Feldman, Brian M $u Division of Rheumatology, Department of Pediatrics, University of Toronto and The Hospital for Sick Children, Toronto, Canada.
- 700 1_
- $a Torre, Ignacio Garcia-De La $u Department of Immunology and Rheumatology, Hospital General de Occidente, Secretaría de Salud, and University of Guadalajara, Guadalajara, Jalisco, Mexico.
- 700 1_
- $a Gordon, Patrick $u Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK.
- 700 1_
- $a Hayashi, Taichi $u Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
- 700 1_
- $a Katz, James D $u National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
- 700 1_
- $a Kohsaka, Hitoshi $u Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
- 700 1_
- $a Lachenbruch, Peter A $u Department of Public Health, Oregon State University, Corvallis, Oregon, USA.
- 700 1_
- $a Lang, Bianca A $u Division of Rheumatology, Department of Pediatrics, IWK Health Centre and Dalhousie University, Halifax, Canada.
- 700 1_
- $a Li, Yuhui $u Department of Rheumatology and Immunology, People's Hospital of Beijing University, Beijing, China.
- 700 1_
- $a Oddis, Chester V $u Division of Rheumatology and Clinical Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- 700 1_
- $a Olesinska, Marzena $u Connective Tissue Diseases Department, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
- 700 1_
- $a Reed, Ann M $u Department of Pediatrics, Duke University, Durham, North Carolina, USA.
- 700 1_
- $a Rutkowska-Sak, Lidia $u Paediatric Clinic of Rheumatology, Institute of Rheumatology, Warsaw, Poland.
- 700 1_
- $a Sanner, Helga $u Section of Rheumatology, Oslo University Hospital-Rikshospitalet, Oslo, Norway.
- 700 1_
- $a Selva-O'Callaghan, Albert $u Vall d'Hebron General Hospital, Barcelona, Spain.
- 700 1_
- $a Song, Yeong-Wook $u Department of Internal Medicine, Medical Research Center, Clinical Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
- 700 1_
- $a Vencovsky, Jiri $u Department of Rheumatology, Institute of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Ytterberg, Steven R $u Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, New York, USA.
- 700 1_
- $a Miller, Frederick W $u US Department of Health and Human Services, Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland, USA.
- 700 1_
- $a Rider, Lisa G $u US Department of Health and Human Services, Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, Maryland, USA.
- 700 1_
- $a ,
- 773 0_
- $w MED00000444 $t Annals of the rheumatic diseases $x 1468-2060 $g Roč. 76, č. 12 (2017), s. 1955-1964
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29079590 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515104132 $b ABA008
- 999 __
- $a ok $b bmc $g 1299876 $s 1013092
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 76 $c 12 $d 1955-1964 $e 20171027 $i 1468-2060 $m Annals of the rheumatic diseases $n Ann Rheum Dis $x MED00000444
- LZP __
- $a Pubmed-20180515
